- Tytuł:
- A propensity score‐matched, real‐world comparison of ustekinumab vs vedolizumab as a second‐line treatment for Crohn's disease. The Cross Pennine study II.
- Autorzy:
- Źródło:
- Alimentary Pharmacology & Therapeutics. Apr2022, Vol. 55 Issue 7, p856-866. 11p. 4 Charts, 2 Graphs.
Czasopismo naukowe